TTD | Drug: D0Z4AC

Drug General Information
Drug ID	D0Z4AC
Former ID	DNC013202
Drug Name	2-amino-N1-benzyl-N3-hydroxymalonamide
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[528703]
Structure		Download 2D MOL 3D MOL
Formula	C10H13N3O3
Canonical SMILES	C1=CC=C(C=C1)CNC(=O)C(C(=O)NO)N
InChI	1S/C10H13N3O3/c11-8(10(15)13-16)9(14)12-6-7-4-2-1-3-5-7/h1-5,8,16H,6,11H2,(H,12,14)(H,13,15)
InChIKey	HVTWOBIOCPYSGH-UHFFFAOYSA-N
PubChem Compound ID	16115628
Target and Pathway
Target(s)	Aminopeptidase N	Target Info	Inhibitor	[528703]
BioCyc Pathway	Glutathione-mediated detoxification
KEGG Pathway	Glutathione metabolism
	Metabolic pathways
	Renin-angiotensin system
	Hematopoietic cell lineage
Pathway Interaction Database	C-MYB transcription factor network
PathWhiz Pathway	Glutathione Metabolism
Reactome	Metabolism of Angiotensinogen to Angiotensins
WikiPathways	Metabolism of Angiotensinogen to Angiotensins
	Cardiac Progenitor Differentiation
	miR-targeted genes in squamous cell - TarBase
	miR-targeted genes in muscle cell - TarBase
	miR-targeted genes in lymphocytes - TarBase
	miR-targeted genes in leukocytes - TarBase
	Glutathione metabolism
References
Ref 528703	J Med Chem. 2007 Mar 22;50(6):1322-34. Epub 2007 Feb 28.Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents.
Ref 528703	J Med Chem. 2007 Mar 22;50(6):1322-34. Epub 2007 Feb 28.Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information